Category Archives: Events

18Jan/18
woman with fitbit

How the Internet of Medical Things (IoMT) Supports Improved Patient Outcomes

Webinar Recording Available On-Demand

By: Sandra K. Rodriguez, Market Analyst, Axendia

The Internet of Medical Things (IoMT) and the transition to outcomes based reimbursements are changing the way medical device companies approach new product development. IoMT and connected healthcare can enable the transition to patient-centered, preventative care.  IoMT connected devices are going to play an important role in supporting improved quality of care, patient outcomes, and also improving the business of healthcare in the outcome economy.  Yet with smart, connected products comes a new level of complexity throughout the total product lifecycle

In a recent FDANews webinar, I was joined by David Wolf and Jordan Reynolds, both Senior Managers with Kalypso.  We discussed the impact the increased number of connected IoMT devices is having on outcome based healthcare models, the potential benefits and pitfalls, and how to best leverage PLM solutions and IoT in a changing healthcare environment. Continue reading

11Jan/18
2017 Year end review

Award Winning Year for Axendia – Looking at the 2018 Crystal Ball

By Daniel R. Matlis

2017 has been an exceptional year for Axendia.  We were recognized by CIOReview magazine as one of the 20 Most Promising Pharma and Life Sciences Solution Providers.  We also had the opportunity to address audiences around the globe, including Asia, Europe, North and South America.

Our analysts had the privilege to provide insight and trusted advice to leaders across the Life Science and Healthcare ecosystems including executives in industry, technology & service providers as well as policy makers and regulators.
In the last year we advised our clients on critical topics such as:

11Dec/17
Moped

Compliance vs Quality – India Edition

By Daniel R. Matlis

In October, I had the privilege to visit Mumbai, India, to provide the keynote address at a series of Life-Science Executive Industry events on Quality and Manufacturing organized by Dassault Systèmes Biovia Corp.

GroupThis visit afforded me a great opportunity to meet with executives from many of India’s largest Life-Science companies, get a taste of Indian culture and share Axendia’s insights on trends impacting the global and externalized industry.

I also gained a new perspective on the Compliance vs Quality paradox.

During my keynote I emphasized the need for Life-Science Organizations to transition their focus from mere Compliance towards a culture driving Quality improvements across the organization.

Compliance is a Baseline, it is the cost of doing business in the Life-Sciences Industry.  Collecting documented evidence of compliance with regulatory requirements is an overhead cost for Life-Science companies.

By contrast, Quality is an Investment. Improvements in quality drive enhanced and consistent product performance.  In addition streamlined processes result in operational efficiencies and reduce waste.  Investing in improving product quality lowers costs and improves outcomes

Continue reading

16Oct/17
Image Courtesy of Forbes

When it Comes to 3D Printing, the Future is Already Here

Webinar Availalbe On-Demand – Experts Share Real World Insights 

By:  Eric Luyer, Market Research Analyst

According to the FDA, when it comes to 3D printing, you might say that the future is already here. Due to its versatility, the agency is evaluating the applications of 3D printing in devices, drugs and biologics and to medical applications across the entire ecosystem.

To gain first hand insight on the use of 3D printing in Life Sciences and Healthcare, Axendia assembled an expert panel for a roundtable discussion:3d printing panelists

  • Thomas Marchand, Co-Founder & CEO of BIOMODEX provided the industry perspective
  • Jenny Chen, a trained neuro-radiologist and founder/CEO of 3DHEALS, shared the physician’s perspective
  • Stavros Stefanis, leader in Deloitte’s Product Development practice, shared insights on the use of 3D printing across the product development lifecycle

The webinar was held on September 28th and sponsored by Dassault Systèmes (3DS).

3D printing in Life-Sciences is NOT Science Fiction, it is Science FACT

To date, FDA has cleared over 85 applications for 3D-printed medical devices which span across many product lines such as prosthetics and implants and last year, FDA approved the first 3D printed Drug – Aprecia’s Spritam. Continue reading

11Oct/17
SIAC17

New Versions of Everything, New Expectations

Realizing the Digital Twin – 2017 Siemens Analyst Conference

By:  Sandra K. Rodriguez, Market Analyst

The Siemens Analyst Conference took place in Boston from September 6 – 7, 2017.  Dr. Jan Mrosik, CEO Siemens Digital Factory Division, opened the conference with a clear message:

“Digitalization changes everything and a common digital thread enables continuous business transformation!”

Siemens has invested $6.5B since 2013 in its digital enterprise suite, beginning with the acquisition of LMS International which expanded its strategy for system validation and verification.  The company is also seeking to establish a leadership role in electronics and semiconductor product and process simulation by adding Mentor Graphics to its Digital Factory division.

A Digital Twin is not a concept, it is a disruptive technology.  It enables companies to competitively change the way products are realized, come to life and evolve.  Adding digital twin technology within a smart factory offers companies three unique benefits:

  • The ability to predict profitability through analysis of production scenarios
  • Improved efficiencies through the digital thread and virtual commissioning
  • Optimized production through the comparison of real and digital production systems

Continue reading